BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 1845172)

  • 1. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.
    Talaska G; al-Juburi AZ; Kadlubar FF
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5350-4. PubMed ID: 2052611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
    Hatcher JF; Swaminathan S
    Environ Mol Mutagen; 2002; 39(4):314-22. PubMed ID: 12112383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4,4'-Methylene-bis(2-chloroaniline)-DNA adduct analysis in human exfoliated urothelial cells by 32P-postlabeling.
    Kaderlik KR; Talaska G; DeBord DG; Osorio AM; Kadlubar FF
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):63-9. PubMed ID: 8420614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
    Talaska G; Dooley KL; Kadlubar FF
    Carcinogenesis; 1990 Apr; 11(4):639-46. PubMed ID: 2323002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
    Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
    Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I.
    Fernando RC; Schmeiser HH; Nicklas W; Wiessler M
    Carcinogenesis; 1992 Oct; 13(10):1835-9. PubMed ID: 1423842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
    Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
    J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers.
    Hsu TM; Zhang YJ; Santella RM
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):193-9. PubMed ID: 9138663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
    Li D; Wang M; Dhingra K; Hittelman WN
    Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new DNA adducts in human bladder epithelia exposed to the proximate metabolite of 4-aminobiphenyl using 32P-postlabeling method.
    Swaminathan S; Hatcher JF
    Chem Biol Interact; 2002 Feb; 139(2):199-213. PubMed ID: 11823007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogen-DNA adducts in exfoliated urothelial cells: techniques for noninvasive human monitoring.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Kadlubar F; Bartsch H; Vineis P
    Environ Health Perspect; 1993 Mar; 99():289-91. PubMed ID: 8319646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
    Mourato LL; Beland FA; Marques MM
    Chem Res Toxicol; 1999 Jul; 12(7):661-9. PubMed ID: 10409407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.